INS and Alzheimer disease: The KD shows anti-inflammatory effects, decreases apolipoprotein E glycation, modulates neurotransmitter levels, improves mitochondrial deficits, increases insulin sensitivity, and alters the state of hypometabolism (GLUT-1 deficiency) [143,144] prominent in AD [95].